Skip to main content
. 2012 Oct 19;7(10):e47485. doi: 10.1371/journal.pone.0047485

Table 2. Components of the VS411 capsules.

Capsule Type Components Resulting Doses
VS411-A 2 ddIa 100 mg ECb tablets/2 HCc 150 mg tablets ddI: 200 mg/HC: 300 mg
VS411-B 2 ddI placebo EC tablets/2 HC 150 mg tablets ddI: 0 mg/HC: 300 mg
VS411-C 2 ddI 100 mg EC tablets/2 HC placebo tablets ddI: 200 mg/HC: 0 mg
VS411-D 2 ddI placebo EC tablets/2 HC placebo tablets ddI: 0 mg/HC: 0 mg
a

ddI  =  didanosine.

b

EC  =  Enterically coated.

c

HC  =  hydroxycarbamide.